207 related articles for article (PubMed ID: 31485631)
21. Tanshinone IIA induces apoptosis in human oral cancer KB cells through a mitochondria-dependent pathway.
Tseng PY; Lu WC; Hsieh MJ; Chien SY; Chen MK
Biomed Res Int; 2014; 2014():540516. PubMed ID: 24900970
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.
Xu H; Li H; Zhu P; Liu Y; Zhou M; Chen A
Drug Des Devel Ther; 2020; 14():2853-2863. PubMed ID: 32764884
[TBL] [Abstract][Full Text] [Related]
27. Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.
Zu Y; Wang J; Ping W; Sun W
Mol Med Rep; 2018 Feb; 17(2):2384-2392. PubMed ID: 29207086
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
29. Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.
Zhang Y; Li S; He H; Han Q; Wang B; Zhu Y
Thorac Cancer; 2017 Jul; 8(4):296-303. PubMed ID: 28407361
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA inhibits cell growth by suppressing SIX1-induced aerobic glycolysis in non-small cell lung cancer cells.
Qi H; Chen Z; Qin Y; Wang X; Zhang Z; Li Y
Oncol Lett; 2022 Jun; 23(6):184. PubMed ID: 35527783
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines.
Wang L; Wu J; Lu J; Ma R; Sun D; Tang J
Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
36. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
[TBL] [Abstract][Full Text] [Related]
37. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of telomerase activity and activation of caspase-3 are responsible for Tanshinone I-induced apoptosis in monocyte leukemia cells in vitro.
Liu XD; Fan RF; Zhang Y; Yang HZ; Fang ZG; Guan WB; Lin DJ; Xiao RZ; Huang RW; Huang HQ; Liu PQ; Liu JJ
Int J Mol Sci; 2010 May; 11(6):2267-80. PubMed ID: 20640151
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway.
Zhou Y; Zhang H; Huang Y; Wu S; Liu Z
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36069225
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
